These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34064815)

  • 1. Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia.
    Krysiak R; Basiak M; Okopień B
    Molecules; 2021 May; 26(10):. PubMed ID: 34064815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia.
    Krysiak R; Basiak M; Szkróbka W; Okopień B
    J Clin Pharmacol; 2023 Mar; 63(3):345-351. PubMed ID: 36222207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Lisinopril on Cardiometabolic Risk Factors in Men With Hypertension and Early-onset Androgenetic Alopecia: A Pilot Study.
    Krysiak R; Basiak M; Okopień B
    J Cardiovasc Pharmacol; 2021 Nov; 78(5):e738-e742. PubMed ID: 34321400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
    Krysiak R; Szkróbka W; Okopień B
    Pharmacol Rep; 2021 Feb; 73(1):261-268. PubMed ID: 32696349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired metabolic effects of metformin in men with early-onset androgenic alopecia.
    Krysiak R; Kowalcze K; Okopień B
    Pharmacol Rep; 2022 Feb; 74(1):216-228. PubMed ID: 34897595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Telmisartan on Cardiometabolic Risk Factors in Hypertensive Male Siblings of Women With Polycystic Ovary Syndrome.
    Krysiak R; Basiak M; Szkróbka W; Okopień B
    J Clin Pharmacol; 2021 Sep; 61(9):1165-1173. PubMed ID: 33837974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of exogenous vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia.
    Krysiak R; Kowalcze K; Okopień B
    Pharmacol Rep; 2021 Oct; 73(5):1439-1447. PubMed ID: 34106452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis.
    Krysiak R; Kowalcze K; Okopień B
    Pharmacology; 2023; 108(3):255-264. PubMed ID: 36878199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.
    Krysiak R; Kowalcze K; Okopień B
    Pharmacology; 2023; 108(5):451-459. PubMed ID: 37536301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia.
    Krysiak R; Gilowski W; Okopien B
    Cardiovasc Ther; 2015 Oct; 33(5):270-4. PubMed ID: 26031507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinaemia modulates cardiometabolic effects of fenofibrate in men with atherogenic dyslipidaemia: A pilot study.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharm Ther; 2020 Feb; 45(1):115-121. PubMed ID: 31444987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2021 Jan; 129(1):7-13. PubMed ID: 31185509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary Effects of Metformin in Men With Early-Onset Androgenic Alopecia.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharmacol; 2022 Nov; 62(11):1364-1371. PubMed ID: 35603693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
    Krysiak R; Kowalcze K; Bednarska-Czerwińska A; Okopień B
    Pharmacol Rep; 2019 Jun; 71(3):417-421. PubMed ID: 31003151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of rosuvastatin on hypothalamic-pituitary-testicular axis activity in metformin-treated and metformin-naïve men with low testosterone levels: a pilot study.
    Krysiak R; Basiak M; Szkróbka W; Okopień B
    Pharmacol Rep; 2021 Oct; 73(5):1465-1472. PubMed ID: 34086261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharmacol; 2023 Sep; 63(9):1045-1052. PubMed ID: 37173821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Pharmacol Rep; 2019 Feb; 71(1):61-66. PubMed ID: 30469130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fenofibrate on cardiometabolic risk factors in bromocriptine-treated women with mixed dyslipidemia: A pilot study.
    Krysiak R; Okrzesik J; Szkrobka W; Okopień B
    Pharmacol Rep; 2016 Feb; 68(1):185-9. PubMed ID: 26721371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of vitamin D status on cardiometabolic effects of fenofibrate in women with atherogenic dyslipidemia.
    Krysiak R; Kowalcze K; Okopień B
    Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):186-194. PubMed ID: 33098674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Macroprolactinemia on Cardiometabolic Effects of Atorvastatin in Women With Hypercholesterolemia.
    Krysiak R; Kowalcze K; Okopień B
    Am J Cardiol; 2019 Oct; 124(8):1207-1212. PubMed ID: 31409451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.